Transglutaminase 2 (TG2) inhibitor (IC50
= 0.25 μ
M). Binds at GTPase site; reversible.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.
Prime et al.
Structure-activity relationship study of novel tissue transglutaminase inhibitors.
Duval et al.
Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
Case and Stein
The citations listed below are publications that use Tocris products. Selected citations for LDN 27219 include:
Showing Results 1 - 1 of 1